Clinical Trial Update: Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluated weekly erythropoietin dosing in preterm infants; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Infant Health Conditions
• Preterm Infants

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University of New Mexico | Conditions: Preterm Infants | Phase 2 | Status: COMPLETED | Results posted: 2013-07-29